1. Home
  2. PULM vs JVA Comparison

PULM vs JVA Comparison

Compare PULM & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • JVA
  • Stock Information
  • Founded
  • PULM 2003
  • JVA 1971
  • Country
  • PULM United States
  • JVA United States
  • Employees
  • PULM N/A
  • JVA N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • PULM Health Care
  • JVA Consumer Staples
  • Exchange
  • PULM Nasdaq
  • JVA Nasdaq
  • Market Cap
  • PULM 20.5M
  • JVA 23.8M
  • IPO Year
  • PULM N/A
  • JVA 2005
  • Fundamental
  • Price
  • PULM $4.87
  • JVA $4.15
  • Analyst Decision
  • PULM
  • JVA
  • Analyst Count
  • PULM 0
  • JVA 0
  • Target Price
  • PULM N/A
  • JVA N/A
  • AVG Volume (30 Days)
  • PULM 11.0K
  • JVA 31.9K
  • Earning Date
  • PULM 08-06-2025
  • JVA 09-12-2025
  • Dividend Yield
  • PULM N/A
  • JVA N/A
  • EPS Growth
  • PULM N/A
  • JVA 856.08
  • EPS
  • PULM N/A
  • JVA 0.65
  • Revenue
  • PULM $369,000.00
  • JVA $84,651,329.00
  • Revenue This Year
  • PULM N/A
  • JVA N/A
  • Revenue Next Year
  • PULM $134.88
  • JVA N/A
  • P/E Ratio
  • PULM N/A
  • JVA $6.43
  • Revenue Growth
  • PULM N/A
  • JVA 15.86
  • 52 Week Low
  • PULM $1.78
  • JVA $1.86
  • 52 Week High
  • PULM $10.40
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • PULM 44.33
  • JVA 47.53
  • Support Level
  • PULM $4.65
  • JVA $4.05
  • Resistance Level
  • PULM $5.00
  • JVA $4.20
  • Average True Range (ATR)
  • PULM 0.16
  • JVA 0.10
  • MACD
  • PULM 0.06
  • JVA 0.00
  • Stochastic Oscillator
  • PULM 76.92
  • JVA 42.31

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: